Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -3.96% | 58.19 | 0.0% | $1899.37m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.26% | 597.00 | 2.5% | $1174.48m | |
| GILD | Gilead Sciences, Inc. | -1.02% | 76.75 | 1.0% | $975.82m | |
| AMGN | Amgen, Inc. | 2.17% | 225.67 | 1.3% | $660.44m | |
| NVAX | Novavax, Inc. | 3.67% | 46.30 | 102.0% | $655.72m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -2.61% | 265.69 | 1.9% | $544.78m | |
| ILMN | Illumina, Inc. | -1.20% | 354.11 | 3.5% | $388.06m | |
| BIIB | Biogen, Inc. | 2.36% | 306.72 | 1.6% | $378.26m | |
| SRNE | Sorrento Therapeutics, Inc. | 6.74% | 4.12 | 1.8% | $269.11m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.35% | 115.21 | 2.0% | $241.70m | |
| SGEN | Seattle Genetics, Inc. | -1.36% | 148.39 | 6.1% | $223.95m | |
| A | Agilent Technologies, Inc. | -0.83% | 90.38 | 1.6% | $215.81m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -1.59% | 105.80 | 4.3% | $184.97m | |
| SRPT | Sarepta Therapeutics, Inc. | 2.06% | 147.99 | 13.9% | $156.63m | |
| INCY | Incyte Corp. | -0.31% | 93.51 | 2.5% | $153.41m |
Company Profile
Dynavax Technologies Corp. operates as a biopharmaceutical company, which engages in the discovery, development and commercialization of novel vaccines and immuno-oncology therapeutics. The firm focuses on leveraging the body's innate and adaptive immune responses through toll-like receptor stimulation. It offers products for vaccines, cancer immunotherapy, and immune-mediated diseases. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Berkeley, CA.